This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Neunteufl, T. Articles by Weidinger, F. Search for Related Content PubMed PubMed Citation Articles by Neunteufl, T. Articles by Weidinger, F.

CLINICAL STUDIES

Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men

^a Department of Cardiology, University of Vienna, Vienna, Austria
^b Department of Vascular Medicine, University of Vienna, Vienna, Austria

Manuscript received December 11, 1997; revised manuscript received May 11, 1998, accepted May 20, 1998.

Address for correspondence: Dr. Franz Weidinger, Department of Cardiology, University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria

Objectives. The aim of this study was to determine whether the combination of lipid-lowering therapy and vitamin E supplementation improves peripheral endothelial function and whether it is more effective than lipid-lowering therapy alone.

Background. Endothelium-dependent vasodilation is impaired in coronary and peripheral arteries of patients with hypercholesterolemia. Coronary endothelial function has been shown to improve under lipid-lowering and antioxidant therapy, but the effect of additive vitamin E supplementation in the brachial artery is unknown.

Methods. Seven patients with hypercholesterolemia (mean ± SD; age 51 ± 10 yr) were studied. Endothelium-dependent, flow-mediated dilation (FMD) and endothelium-independent nitroglycerin-induced dilation (NMD) were assessed in the brachial artery using high resolution ultrasound 1) at baseline (BL I), 2) after 8 weeks of simvastatin (20 mg) and vitamin E (300 IU) therapy (Comb I), 3) after withdrawal of vitamin E for 4 weeks (Statin), 4) after therapy as in #2 for 4 weeks (Comb II) and 5) after withdrawal of both drugs for 4 weeks (BL II).

Results. Combined simvastatin and vitamin E therapy reduced total cholesterol (Comb I vs. BL I: 276 ± 22 vs. 190 ± 14 mg/dl, p < 0.0001) and low-density lipoprotein (LDL)-C (197 ± 22 vs. 106 ± 22 mg/dl, p < 0.00001), augmented alpha tocopherol levels normalized to LDL (12.2 ± 4.1 vs. 4.9 ± 0.9 µg alpha-T/100 mg% LDL-C, p < 0.01) and resulted in significant improvements in FMD (16.4 ± 4.7 vs. 4.9 ± 2.5%, p < 0.001) as well as NMD (17.9 ± 4.3 vs. 11.2 ± 2.8%, p < 0.01). The ratio of FMD to NMD (0.92 ± 0.17 vs. 0.46 ± 0.24%, p < 0.05) also increased under combination therapy, indicating a greater improvement of FMD than that of NMD. After withdrawal of vitamin E, both FMD (Comb I vs. Statin: 16.4 ± 4.7 vs. 7.9 ± 4.7%, p < 0.01) and NMD (17.9 ± 4.3 vs. 10.9 ± 4.5%, p < 0.05) decreased significantly such that simvastatin alone only tended to improve FMD and did not change NMD. Results under combination therapy (Comb II vs. BL II) were reproducible.

Conclusions. Combined vitamin E and simvastatin therapy leads to an improvement of FMD and NMD in the brachial artery of patients with hypercholesterolemia. The improvement of FMD is more pronounced after combination therapy than after lipid-lowering therapy alone, similar to previous findings in the coronary circulation.

Abbreviations and Acronyms   BL = baseline   Comb = combined therapy   FMD = flow-mediated vasodilation   LDL-C = low-density lipoprotein-cholesterol   NMD = nitroglycerin-induced vasodilation   NTG = nitroglycerin   Statin = simvastatin therapy

This article has been cited by other articles:

				M. Miner Fitness, Antioxidants, and Moderate Drinking: All to Lower Cardiovascular Risk American Journal of Lifestyle Medicine, March 1, 2007; 1(2): 110 - 112. [Abstract] [PDF]

				D. Tousoulis, C. Antoniades, C. Vassiliadou, M. Toutouza, C. Pitsavos, C. Tentolouris, A. Trikas, and C. Stefanadis Effects of combined administration of low dose atorvastatin and vitamin E on inflammatory markers and endothelial function in patients with heart failure Eur J Heart Fail, December 1, 2005; 7(7): 1126 - 1132. [Abstract] [Full Text] [PDF]

				M. L. Bots, J. Westerink, T. J. Rabelink, and E. J.P. de Koning Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response Eur. Heart J., February 2, 2005; 26(4): 363 - 368. [Abstract] [Full Text] [PDF]

				R. Stocker and J. F. Keaney Jr. Role of Oxidative Modifications in Atherosclerosis Physiol Rev, October 1, 2004; 84(4): 1381 - 1478. [Abstract] [Full Text] [PDF]

				S. Y. Chan, G. B. J. Mancini, L. Kuramoto, M. Schulzer, J. Frohlich, and A. Ignaszewski The prognostic importance of endothelial dysfunction and carotid atheromaburden in patients with coronary artery disease J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1037 - 1043. [Abstract] [Full Text] [PDF]

				M. M. Engler, M. B. Engler, M. J. Malloy, E. Y. Chiu, M. C. Schloetter, S. M. Paul, M. Stuehlinger, K. Y. Lin, J. P. Cooke, J. D. Morrow, et al. Antioxidant Vitamins C and E Improve Endothelial Function in Children With Hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial Circulation, September 2, 2003; 108(9): 1059 - 1063. [Abstract] [Full Text] [PDF]

				G. D. Plotnick, M. C. Corretti, R. A. Vogel, R. Hesslink Jr, and J. A. Wise Effect of supplemental phytonutrients on impairment of the flow-mediated brachialartery vasoactivity after a single high-fat meal J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1744 - 1749. [Abstract] [Full Text] [PDF]

				J. H. Stein, C. M. Carlsson, K. Papcke-Benson, S. E. Aeschlimann, A. Bodemer, M. Carnes, and P. E. McBride The effects of lipid-lowering and antioxidant vitamin therapies on flow-mediated vasodilation of the brachial artery in older adults with hypercholesterolemia J. Am. Coll. Cardiol., December 1, 2001; 38(7): 1806 - 1813. [Abstract] [Full Text] [PDF]

				J. T. Kuvin, A. R. Patel, K. A. Sliney, N. G. Pandian, W. M. Rand, J. E. Udelson, and R. H. Karas Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease J. Am. Coll. Cardiol., December 1, 2001; 38(7): 1843 - 1849. [Abstract] [Full Text] [PDF]

				M. A van de Ree, M. V Huisman, F. H de Man, J. C van der Vijver, A.E. Meinders, and G. J Blauw Impaired endothelium-dependent vasodilation in type 2 diabetes mellitus and the lack of effect of simvastatin Cardiovasc Res, November 1, 2001; 52(2): 299 - 305. [Abstract] [Full Text] [PDF]

				F. Visioli Effects of vitamin E on the endothelium: equivocal? {alpha}-tocopherol and endothelial dysfunction Cardiovasc Res, August 1, 2001; 51(2): 198 - 201. [Full Text] [PDF]

				A. C. Carr, B.-Z. Zhu, and B. Frei Potential Antiatherogenic Mechanisms of Ascorbate (Vitamin C) and {alpha}-Tocopherol (Vitamin E) Circ. Res., September 1, 2000; 87(5): 349 - 354. [Abstract] [Full Text] [PDF]

				D. Tomasian, J. F. Keaney Jr., and J. A. Vita Antioxidants and the bioactivity of endothelium-derived nitric oxide Cardiovasc Res, August 18, 2000; 47(3): 426 - 435. [Full Text] [PDF]

				R. A. P. Skyrme-Jones, R. C. O'Brien, K. L. Berry, and I. T. Meredith Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study J. Am. Coll. Cardiol., July 1, 2000; 36(1): 94 - 102. [Abstract] [Full Text] [PDF]

				K. J. Williams, R. Scalia, K. D. Mazany, W. V. Rodrigueza, and A. M. Lefer Rapid Restoration of Normal Endothelial Functions in Genetically Hyperlipidemic Mice by a Synthetic Mediator of Reverse Lipid Transport Arterioscler Thromb Vasc Biol, April 1, 2000; 20(4): 1033 - 1039. [Abstract] [Full Text] [PDF]

				T. Neunteufl, U. Priglinger, S. Heher, M. Zehetgruber, G. Soregi, S. Lehr, K. Huber, G. Maurer, F. Weidinger, and K. Kostner Effects of vitamin E on chronic and acute endothelial dysfunction in smokers J. Am. Coll. Cardiol., February 1, 2000; 35(2): 277 - 283. [Abstract] [Full Text] [PDF]

				K. K. Koh, A. Blum, L. Hathaway, R. Mincemoyer, G. Csako, M. A. Waclawiw, J. A. Panza, and R. O. Cannon III Vascular Effects of Estrogen and Vitamin E Therapies in Postmenopausal Women Circulation, November 2, 1999; 100(18): 1851 - 1857. [Abstract] [Full Text] [PDF]

				J. H. Stein, J. G. Keevil, D. A. Wiebe, S. Aeschlimann, and J. D. Folts Purple Grape Juice Improves Endothelial Function and Reduces the Susceptibility of LDL Cholesterol to Oxidation in Patients With Coronary Artery Disease Circulation, September 7, 1999; 100(10): 1050 - 1055. [Abstract] [Full Text] [PDF]

				J. F. KEANEY JR., D. I. SIMON, and J. E. FREEDMAN Vitamin E and vascular homeostasis: implications for atherosclerosis FASEB J, June 1, 1999; 13(9): 965 - 975. [Abstract] [Full Text]

				K. Kugiyama, T. Motoyama, H. Doi, H. Kawano, N. Hirai, H. Soejima, Y. Miyao, K. Takazoe, Y. Moriyama, Y. Mizuno, et al. Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoproteins levels J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1512 - 1518. [Abstract] [Full Text] [PDF]